Electrical Stimulation in Traumatic Brain Injury (TBI) Induced Aphasia
The Effect of Transcranial Direct Current Stimulation (tDCS) on Naming Ability in Patients With Traumatic Brain Injury Induced Aphasia
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Agnes Floeel, Prof
- Phone Number: +49 3834 86 6815
- Email: agnes.floeel@uni-greifswald.de
Study Contact Backup
- Name: Katharina Wuesten, PhD
- Phone Number: +49 3834 86 6754
- Email: Katharina.wuesten@uni-greifswald.de
Study Locations
-
-
-
Greifswald, Germany, 17475
- Recruiting
- University Medicine Greifswald
-
Contact:
- Agnes Floeel, Prof
- Phone Number: +49 3834 86 6815
- Email: agnes.floeel@uni-greifswald.de
-
Contact:
- Katharina Wuesten, PhD
- Phone Number: +49 3834 86 6754
- Email: Katharina.wuesten@uni-greifswald.de
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aphasia assessed by Aachener Aphasie Test (AAT) > 6 month after moderate TBI
- Age: 18 - 80 years
- right handedness
Exclusion Criteria:
- dementia or other neurological diseases
- History of severe alcoholism or use of drugs
- Severe psychiatric disorders such as depression, psychosis (if not in remission)
- Severe untreated medical problems such as cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: stimulation group
|
anodal tDCS or sham stimulation will be combined with an intensive naming training and the number of items that could be named will be assessed immediately after the intervention.
|
|
SHAM_COMPARATOR: sham stimulation
|
anodal tDCS or sham stimulation will be combined with an intensive naming training and the number of items that could be named will be assessed immediately after the intervention.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Naming ability assessed by
Time Frame: 2 weeks
|
Performance in a standardised naming task (Boston Naming Task, BNT) under anodal tDCS compared to sham assessed immediately after training period
|
2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Agnes Floeel, Prof, University Medicine Greifswald
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Craniocerebral Trauma
- Trauma, Nervous System
- Language Disorders
- Communication Disorders
- Speech Disorders
- Brain Injuries
- Wounds and Injuries
- Brain Injuries, Traumatic
- Aphasia
Other Study ID Numbers
Other Study ID Numbers
- BISCUIT Trial 2019
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.